Octopath AI raises GBP 1.5M in a Seed funding round led by TwinPath Ventures. The capital will support clinical evaluation and regulatory work for its AI-powered diagnostic platform.
Amount Raised
£1.5 Million
Round Type
Seed
United KingdomBiotechnologyArtificial IntelligenceMachine LearningHealth DiagnosticsInvestors
Description
Octopath AI, a UCL spinout specializing in AI tools for cancer pathology, raised GBP 1.5 million in seed funding. The funding is led by TwinPath Ventures with additional support from Innovate UK's Growth Catalyst grant. The capital will be used for clinical evaluation and regulatory approval of their AI diagnostic platform. Founded in 2026, Octopath AI aims to revolutionize cancer diagnostics with advanced technology.
Who to call at Octopath AI, and when
A new round usually means Octopath AI is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Octopath AI raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Octopath AI, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Octopath AI. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Octopath AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Octopath AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.